Stay updated on Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial

Sign up to get notified when there's something new on the Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:27:20.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page shows a new revision note (v3.4.2). A funding/status notice and the earlier revision (v3.4.1) have been removed.
    Difference
    0.4%
    Check dated 2026-02-11T14:00:33.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide status notice about potential delays in updates due to government funding and the NIH Clinical Center's operating status was added, and a new revision tag (v3.4.1) was introduced. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:19:55.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page adds a glossary display option and updates several labels for capitalization (Met vs met and Data vs data) along with the revision tag to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T06:14:19.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page shows a small version update: Revision: v3.3.4 replaces v3.3.3 and does not modify study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:34:59.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added locations Nantes Cedex 1 and Paris 7 to the study locations and updated the revision from v3.3.2 to v3.3.3; the HHS Vulnerability Disclosure link was removed.
    Difference
    0.3%
    Check dated 2025-12-23T22:32:14.000Z thumbnail image

Stay in the know with updates to Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial page.